PPA
CRDF icon

Parametric Portfolio Associates’s Cardiff Oncology CRDF Stock Holding History

Parametric Portfolio Associates’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$76K Buy
+30,601
New +$108K ﹤0.01% 3594
2021
Q4 		– Sell
-15,039
Closed -$100K – 3651
2021
Q3 		$100K Buy
+15,039
New +$94.5K ﹤0.01% 3534
2020
Q4 		– Sell
-94,691
Closed -$1.34M – 4000
2020
Q3 		$1.34M Buy
+94,691
New +$625K ﹤0.01% 2730

Other funds holding CRDF

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Parametric Portfolio Associates's CRDF Position: Q1 2022 in Review

Parametric Portfolio Associates opened a new position in Cardiff Oncology (CRDF) in Q1 2022: 30,601 shares worth $76K. The stake represents ﹤0.01% of the portfolio and ranks #3594 among its holdings. This is a return to the name: Parametric Portfolio Associates previously reported a position in CRDF as recently as Q3 2021.

Parametric Portfolio Associates first reported a position in CRDF in Q3 2020 and has held it in 3 quarters since. The position peaked at $1.34M in Q3 2020. 91 funds tracked by Wall St. Rank hold CRDF as of Q1 2022.

  • Parametric Portfolio Associates held 30,601 shares of Cardiff Oncology worth $76K as of Q1 2022.
  • Cardiff Oncology was a new Parametric Portfolio Associates position in Q1 2022.
  • Cardiff Oncology made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3594 holding.
  • Parametric Portfolio Associates first reported a position in Cardiff Oncology in Q3 2020 and has held it in 3 quarters since.
  • Parametric Portfolio Associates's Cardiff Oncology position peaked at $1.34M in Q3 2020.
  • 91 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.